Overdiagnosis due to breast cancer screening: updated estimates of the Helsinki service study in Finland

BACKGROUND: Overdiagnosis is the most important adverse event of breast cancer screening with the estimates ranging from 0% to 40–50% depending on invitational age and methods. We updated the estimates of overdiagnosis in Helsinki service screening study in Finland by comparing the observed and expe...

Descripción completa

Detalles Bibliográficos
Autores principales: Heinävaara, S, Sarkeala, T, Anttila, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183845/
https://www.ncbi.nlm.nih.gov/pubmed/25121953
http://dx.doi.org/10.1038/bjc.2014.413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183845/
https://www.ncbi.nlm.nih.gov/pubmed/25121953
http://dx.doi.org/10.1038/bjc.2014.413

Ejemplares similares